Comparing Instrument Assisted Soft Tissue Mobilization With Positional Release Technique for Plantar Fasciitis Pain and Range of Motion
Launched by DOAA SAID MOHAMED IBRAHIM · Jul 15, 2025
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinically diagnosed cases of plantar fasciitis not less than 3 months.
- • 2. Heel pain felt maximally over plantar aspect of heel.
- • 3. Pain in the heel on the first step in the morning.
- • 4. Their age ranging from 30 to 50 years
- Exclusion Criteria:
- • 1. Subjects can't tolerate close physical contact (Kotwalkar et al., 2019).
- • 2. Athletes.
- • 3. Subjects with skin infections (Kotwalkar et al., 2019).
- • 4. Subjects with recent fracture with incomplete bony union (Rowlett et al., 2018).
- • 5. Subjects with acute inflammatory or infectious process (Rowlett et al., 2018).
- • 6. Subjects with hematoma (Rowlett et al., 2018).
- • 7. Subjects with osteoporosis (Looney et al., 2011).
- • 8. Subjects with foot deformity (Kotwalkar et al., 2019).
- • 9. Subjects that take medications that may increase blood clotting (Kotwalkar et al., 2019).
- • 10. Surgery to the ankle or foot (Looney et al., 2011).
About Doaa Said Mohamed Ibrahim
Doaa Said Mohamed Ibrahim is a clinical trial sponsor committed to advancing medical research through the support and oversight of innovative clinical studies. With a focus on ensuring ethical standards, regulatory compliance, and scientific rigor, Doaa Said Mohamed Ibrahim plays a vital role in facilitating the development of new treatments and improving patient outcomes across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Port Said, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported